Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer
Na Zhao(Baylor College of Medicine), Jeffrey M. Rosen(Baylor College of Medicine)
Cited by 29
Related Papers
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
|Journal of Clinical Investigation|2018|260
MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3
|Molecular Cancer|2014|182
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
|Nature Communications|2021|59